Hydroxyurea inhibition of growth and DNA synthesis in Toxoplasma gondii: characterization of a resistant mutant.
Hydroxyurea inhibited the growth and DNA synthesis of Toxoplasma gondii growing in human fibroblast cells. A concentration of 18 micrograms/ml totally suppressed plaque formation. The synthesis of T. gondii RNA was not acutely inhibited. The parasite was equally sensitive to hydroxyurea when grown in wild type or hydroxyurea resistant host cells. With the aid of chemical mutagenesis, we isolated a stable hydroxyurea resistant mutant of T. gondii. This mutant showed no increased ability to incorporate [3H]uracil into its pyrimidine deoxynucleotide pool. Hydroxyurea depressed the [3H]uracil labeling of the pyrimidine deoxynucleotide pool in the wild type parasite but not in the mutant, suggesting that the mutant ribonucleotide reductase was resistant to the inhibitory effect of the drug.
D000818:Animals; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis*; D003845:Deoxycytosine Nucleotides / Q000378:metabolism; D004351:Drug Resistance; D005347:Fibroblasts / Q000469:parasitology; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D009154:Mutation; D012313:RNA / Q000096:biosynthesis; D012264:Ribonucleotide Reductases / Q000378:metabolism; D013942:Thymine Nucleotides / Q000378:metabolism; D014122:Toxoplasma / Q000187:drug effects* / Q000502:physiology
D003845:Deoxycytosine Nucleotides; D013942:Thymine Nucleotides; C024107:2'-deoxycytidine 5'-triphosphate; D012313:RNA; D004247:DNA; D012264:Ribonucleotide Reductases; C024157:thymidine 5'-triphosphate; D006918:Hydroxyurea